These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36348398)

  • 21. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P062 Chromoendoscopy With Magnification Colonoscopy: Analysis of Mucosa of Colon And Ileum In Patients With Gastrointestinal Symptoms Without IBD.
    Izquierdo VP; Florez C; Molano WB; Beltran A; Jaimes D; De Avila J; Casallas AR; Bello J; Gutierrez J; Philippe C; Romero-Sanchez C
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S16. PubMed ID: 37461979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult spondyloarthritis in inflammatory bowel disease.
    Bandinelli F; Manetti M; Ibba-Manneschi L
    Clin Rheumatol; 2016 Feb; 35(2):281-9. PubMed ID: 26354428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors.
    Brophy S; Pavy S; Lewis P; Taylor G; Bradbury L; Robertson D; Lovell C; Calin A
    J Rheumatol; 2001 Dec; 28(12):2667-73. PubMed ID: 11764216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis.
    Rodrigues CE; Vieira WP; Bortoluzzo AB; Gonçalves CR; da Silva JA; Ximenes AC; Bértolo MB; Ribeiro SL; Keiserman M; Menin R; Skare TL; Carneiro S; Azevedo VF; Albuquerque EN; Bianchi WA; Bonfiglioli R; Campanholo C; Carvalho HM; Costa IP; Duarte AP; Kohem CL; Leite NH; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Valim V; Sampaio-Barros PD
    Rev Bras Reumatol; 2012; 52(3):375-83. PubMed ID: 22641592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician.
    Lubrano E; Luchetti MM; Benfaremo D; Mauro D; Ciccia F; Perrotta FM
    Expert Rev Clin Immunol; 2021 Nov; 17(11):1199-1209. PubMed ID: 34622735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort.
    Landi M; Maldonado-Ficco H; Perez-Alamino R; Maldonado-Cocco JA; Citera G; Arturi P; Sampaio-Barros PD; Flores Alvarado DE; Burgos-Vargas R; Santos E; Palleiro D; Gutiérrez MA; Vieyra-Sousa E; Pimentel-Santos F; Paira SO; Berman A; Barrezueta CV; Vazquez-Mellado J; Collantes-Estevez E;
    Medicine (Baltimore); 2016 Dec; 95(51):e5652. PubMed ID: 28002334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies.
    Cozzi G; Scagnellato L; Lorenzin M; Savarino E; Zingone F; Ometto F; Favero M; Doria A; Vavricka SR; Ramonda R
    Nat Rev Rheumatol; 2023 Aug; 19(8):503-518. PubMed ID: 37386288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal Symptoms and Elevated Levels of Anti-
    Romero-Sánchez C; Bautista-Molano W; Parra V; De Avila J; Rueda JC; Bello-Gualtero JM; Londoño J; Valle-Oñate R
    Int J Rheumatol; 2017; 2017():4029584. PubMed ID: 29213287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for spondyloarthritis in patients with inflammatory bowel diseases.
    Ottaviani S; Tréton X; Forien M; Coralli R; Dauchez A; Stefanescu C; Pelletier AL; Becheur H; Ebstein E; Bouhnik Y; Dieudé P
    Rheumatol Int; 2023 Jan; 43(1):109-117. PubMed ID: 36161358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study.
    Ossum AM; Palm Ø; Lunder AK; Cvancarova M; Banitalebi H; Negård A; Høie O; Henriksen M; Moum BA; Høivik ML;
    J Crohns Colitis; 2018 Jan; 12(1):96-104. PubMed ID: 28961700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: non-malignant oral manifestations in inflammatory bowel diseases.
    Katsanos KH; Torres J; Roda G; Brygo A; Delaporte E; Colombel JF
    Aliment Pharmacol Ther; 2015 Jul; 42(1):40-60. PubMed ID: 25917394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases.
    Benfaremo D; Luchetti MM; Di Carlo M; Laganà B; Picchianti-Diamanti A; Carubbi F; Pica R; Chimenti MS; Lorenzetti R; Scolieri P; Bruzzese V; Benedetti A; Ramonda R; Giacomelli R; Salaffi F; Gabrielli A;
    J Rheumatol; 2021 Feb; 48(2):179-187. PubMed ID: 32669448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice.
    Gomollón F; Seoane-Mato D; Montoro MA; Juanola X; Trujillo-Martin E; Carrillo-Palau M; Matallana V; García-Magallón B; Ber Y; Ramos L; Perez-Pampin E; Ferreiro-Iglesias R; Rodríguez-Alonso L; Marco-Pascual C; Sanz Sanz J;
    Dig Liver Dis; 2022 Jun; 54(6):755-762. PubMed ID: 35039222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review.
    Lauritano D; Boccalari E; Di Stasio D; Della Vella F; Carinci F; Lucchese A; Petruzzi M
    Diagnostics (Basel); 2019 Jul; 9(3):. PubMed ID: 31311171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
    Fauny M; D'Amico F; Bonovas S; Netter P; Danese S; Loeuille D; Peyrin-Biroulet L
    J Crohns Colitis; 2020 Jun; 14(5):688-693. PubMed ID: 31858121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease.
    Beslek A; Onen F; Birlik M; Akarsu M; Akar S; Sari I; Gurler O; Akpinar H; Manisali M; Akkoc N
    Rheumatol Int; 2009 Jun; 29(8):955-7. PubMed ID: 19082597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease.
    Pérez Alamino R; Maldonado Cocco JA; Citera G; Arturi P; Vazquez-Mellado J; Sampaio-Barros PD; Flores D; Burgos-Vargas R; Santos H; Chavez-Corrales JE; Palleiro D; Gutierrez MA; Vieira-Sousa E; Pimentel-Santos FM; Paira S; Berman A; Moreno-Alvarez M; Collantes-Estevez E;
    J Rheumatol; 2011 Aug; 38(8):1656-60. PubMed ID: 21632676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.